CE Mark registration received for the PromarkerD Hub – a software tool used to calculate the risk of kidney disease in patients with type 2 diabetes. Registration complements the recent CE Mark for PromarkerD (MS) giving a complete package of approvals for PromarkerD in the EU and a significant foundation for future regulatory approvals in other jurisdictions, specifically US FDA registration.